ArticleFrontiers in cardiovascular medicine2021

New Oral Anticoagulants vs. Vitamin K Antagonists Among Patients With Cardiac Amyloidosis: Prognostic Impact.

Eve Cariou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.